Home
Sitemap
|
Contact
Home
Therapeutic Areas
Portfolio
Technology Platform
Media
About ACE BioSciences
2006
Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
1
November 13th, 2006 - ACE BioSciences appoints Dr. Roberto Machuca as Operations Manager to scale up manufacture of Travller's Diarrhoea Vaccine
2
September 7th, 2006 - ACE BioSciences and US Naval Medical Research Center collaborate to progress worlds's first Campylobacter vaccine for Travellers's Diarrhoea through phase II trials
3
August 31st, 2006 - ACE BIOSCIENCES' LEAD PRODUCT, THE WORLD'S FIRST COMMERCIAL VACCINE FOR TRAVELLERS' DIARRHOEA CAUSED BY CAMPYLOBACTER ENTERS CLINICAL TRIALS ON SCHEDULE
4
June 26th, 2006 - ACE BioSciences appoints Dr. Petra Schrotz-King to be Chief Scientific Officer as first vaccine, ACE393, nears clinic
5
April 4th, 2006 - ACE BIOSCIENCES APPOINTS DR MICHAEL DARSLEY TO BE CHIEF DEVELOPMENT OFFICER AS LEAD VACCINE NEARS CLINIC
6
March 8th, 2006 - ACE BioSciences and Nordic Vaccine unite to develop fastacting, high protection vaccines
7
March 2nd, 2006 - ACE BIOSCIENCES APPOINTS PRESTIGIOUS VACCINE SCIENTIFIC ADVISORY BOARD
8
January 10th, 2006 - DR CHANTELLE MC CANN JOINS ACE BIOSCIENCES IN KEY SENIOR VACCINOLOGIST ROLE
© ACE BioSciences A/S - Updated June 2009